To identify the patient who had hypothyroidism they used the medication list in medical record and diagnostic codes used for ordering laboratory tests. Individuals who were 18 to 64 without a history of thyroid cancer, hyperthyroidism or pituitary problems were included. Patients were divided to groups based on the level of their TSH (low, normal, mildly elevated, and elevated). About 10,000 patients were included in the study. A control group of about 21,000 patients was added.
The low TSH group (over-treated) had no differences in hospital outcomes, as compared with the control group. In the normal TSH group, there was a lower risk of both death during the hospitalization and readmission after discharge. The intermediate TSH group demonstrated no differences in hospital outcomes. However, the high TSH (> 10 uIU/ml, under-treated) group had a higher hospital stay (about 1.2 days) and also had a higher rate of readmission in 30 and 90 days.
WHAT ARE THE IMPLICATIONS OF THIS STUDY?
This study suggests that under-treatment of hypothyroidism resulting in a continued increase in TSH levels may result in a longer hospital stay or even possibly higher rate of readmission. Interestingly, over-treatment or mild under-treatment did not appear to have any differences compared to those patients with normal thyroid function. There results should lead to additional studies to confirm the findings. However, this study provides a preliminary information regarding the importance of adequately treating hypothyroidism.
— Shirin Haddady, MD